Pafase: Phase II

ICOS reported data from its U.S. Phase II trial in 240 patients with severe sepsis or traumatic injuries at risk for acute respiratory distress syndrome (ARDS). In

Read the full 273 word article

How to gain access

Continue reading with a
two-week free trial.